Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors

By Chandramohan Vidyalakshmi   Mitchell Duane A   Johnson Laura A   Sampson John H   Bigner Darell D  

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 977-990

Future Medicine

Access to resources Recommend Favorite

Microsurgery for Malignant Gliomas

By Yaşargil M.   Kadri Paulo   Yaşargil Dianne  

Journal of Neuro-Oncology, Vol. 69, Iss. 1-3, 2004-08 ,pp. : 67-81

Springer Publishing Company

Access to resources Recommend Favorite

An antisense EGFR oligodeoxynucleotide enveloped in lipofectin^Rinduces growth inhibition in human malignant gliomas in vitro

By Sugawa N.   Ueda S.   Nakagawa Y.   Nishino H.   Nosaka K.   Iwashima A.   Kurimoto M.  

Journal of Neuro-Oncology, Vol. 39, Iss. 3, 1998-09 ,pp. : 237-244

Springer Publishing Company

Access to resources Recommend Favorite

Identification of EGFRvIII-derived CTL Epitopes Restricted by HLA A0201 for Dendritic Cell Based Immunotherapy of Gliomas

By Wu An-hua   Xiao Jing   Anker Lars   Hall Walter   Gregerson Dale   Cavenee Webster   Chen Wei   Low Walter  

Journal of Neuro-Oncology, Vol. 76, Iss. 1, 2006-01 ,pp. : 23-30

Springer Publishing Company

Access to resources Recommend Favorite

Antitumor effects of a xenogeneic survivin bone marrow derived dendritic cell vaccine against murine GL261 gliomas

By Ciesielski Michael   Apfel Lisa   Barone Tara   Castro Carla   Weiss Tina   Fenstermaker Robert  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 12, 2006-12 ,pp. : 1491-1503

Springer Publishing Company

Access to resources Recommend Favorite